41589-43-9

Basic information

• Product Name: Propanedioic acid, 2-cyclohexylidene-, 1,3-diethyl ester
• Synonyms: Propanedioic acid, 2-cyclohexylidene-, 1,3-diethyl ester
• CAS NO: 41589-43-9
• Molecular Formula: C₁₃H₂₀O₄
• Molecular Weight: 240.2955
• Mol File: 41589-43-9.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 289.7°Cat760mmHg
• Flash Point: 133.2°C
• Appearance: /
• Density: 1.085g/cm³
• Vapor Pressure: 0.00216mmHg at 25°C
• Refractive Index: 1.483
• CAS DataBase Reference: Propanedioic acid, 2-cyclohexylidene-, 1,3-diethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanedioic acid, 2-cyclohexylidene-, 1,3-diethyl ester(41589-43-9)
• EPA Substance Registry System: Propanedioic acid, 2-cyclohexylidene-, 1,3-diethyl ester(41589-43-9)

Safety Data

• Hazardous Substances Data: 41589-43-9(Hazardous Substances Data)

Usage

General Description

Propanedioic acid, 2-cyclohexylidene-, 1,3-diethyl ester is a chemical compound used primarily as a fragrance ingredient in perfumes and personal care products. It is a diester formed from the condensation of 2-cyclohexylidenepropanedioic acid and ethanol. Propanedioic acid, 2-cyclohexylidene-, 1,3-diethyl ester is known for its sweet, fruity, and floral odor, and it is often used to impart a pleasant scent to various consumer products. Additionally, it may also have other potential applications in the pharmaceutical and chemical industries, although further research is needed to fully understand its properties and potential uses.

InChI:InChI=1/C13H20O4/c1-3-16-12(14)11(13(15)17-4-2)10-8-6-5-7-9-10/h3-9H2,1-2H3

Upstream product

• 108-94-1 cyclohexanone 
• 105-53-3 diethyl malonate 
• 2043-61-0 cyclohexanecarbaldehyde 
• 120-92-3 cyclopentanone 

Downstream Products

• 128262-20-4 (1-cyanocyclohexyl)malonic acid diethyl ester 
• 1215295-54-7 ethyl 2-ethoxycarbonyl-3-(3-indolyl)-3-(cyclohexyl)propanoate 
• 82495-11-2 2-(1-methylcyclohexyl)ethanol 
• 14352-58-0 (1-methylcyclohexyl)acetic acid 
• 79405-31-5 (1-methylcyclohexyl)acetaldehyde 
• 710942-17-9 1-methylcyclohexyl alanine 
• 666725-89-9 C₂₈H₄₁N₅O₅ 
• 666725-78-6 C₂₈H₄₁N₅O₅ 
• 666726-05-2 C₂₇H₃₈N₄O₆S 
• 698346-11-1 C₂₂H₃₆N₄O₄S 
• 1318803-62-1 C₂₇H₄₄N₄O₆S 
• 1318803-60-9 C₁₅H₂₇NO₄ 
• 1318803-59-6 C₁₀H₁₈N₂ 
• 666725-82-2 C₂₇H₃₆N₄O₆S 

Relevant articles and documents

Enantioselective Catalyst Systems from Copper(II) Triflate and BINOL–Silanediol

Silanediol and copper catalysis are merged, for the first time, to create an enhanced Lewis acid catalyst system for enantioselective heterocycle functionalization. The promise of this silanediol and copper catalyst combination is demonstrated in the enantioselective addition of indoles to alkylidene malonates to give rise to the desirable adducts in excellent yield and high enantiomeric excess. From these studies, 1,1′-bi-2-naphthol (BINOL)-based silanediols emerge as one-of-a-kind cocatalysts. Their potential role in the reaction pathway is also discussed.

Protected amino hydroxy adamantane carboxylic acid and process for its preparation

Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided. The provided compounds can be used for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.

Bronsted base-modulated Regioselective Pd-catalyzed intramolecular aerobic oxidative amination of alkenes: Formation of seven-membered amides and evidence for allylic C-H activation

A novel palladium-catalyzed intramolecular aerobic oxidative allylic C-H amination of olefins has been developed. Bronsted base can modulate the regioselectivity, favoring the formation of 7-membered rings. Mechanistic studies using deuterium-labeled substrates as probes support a rate-determining allylic C-H activation/irreversible reductive elimination pathway.